Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice
- PMID: 10817711
- PMCID: PMC89915
- DOI: 10.1128/AAC.44.6.1575-1577.2000
Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice
Abstract
We examined the relationship between penicillin susceptibility, peritoneal virulence in Swiss mice, and capsular type in a selection of 122 clinical Streptococcus pneumoniae isolates belonging to 24 serotypes. Regardless of the serotype, all 32 virulent strains were susceptible to penicillin, and all 41 strains with diminished susceptibility or resistance to penicillin were avirulent. The remaining 49 strains were both susceptible to penicillin and avirulent, irrespective of the serotype. On the basis of their capsular type and pathogenic behavior, strains fell into one of four groups. In the group consisting of serotypes 1, 3, and 4 (n = 16), strains were predominantly virulent (81.3%), and all were penicillin susceptible. In the serotype 6 group (n = 32), the frequency of virulence was significantly lower (34.4 versus 81.3%, P = 0.002), and strains were predominantly penicillin susceptible (71.9%). In the group composed of serotypes 9, 14, 19, and 23 (n = 50), all strains were avirulent, and 56% had decreased susceptibility (n = 12) or resistance to (n = 16) penicillin. The fourth group was heterogenous, as it pooled 24 strains of 15 different serotypes; in this group the frequency of virulence was 33.3%, and strains were predominantly penicillin susceptible (83.3%). These data point to a complex relationship between penicillin susceptibility and virulence in mice but do not entirely separate these characteristics from the role of the capsular type. The possibility that the mechanisms conferring penicillin resistance are related to those leading to a loss of virulence is supported by these findings.
Figures
References
-
- Appelbaum P C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77–83. - PubMed
-
- Appelbaum P C. Emergence of resistance to antimicrobial agents in gram-positive bacteria-pneumococci. Drugs. 1996;51(Suppl. 1):1–5. - PubMed
-
- Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. Microb Drug Resist. 1997;3:111–115. - PubMed
-
- Azoulay-Dupuis E, Vallée E, Veber B, Bédos J P, Bauchet J, Pocidalo J J. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob Agents Chemother. 1992;36:2698–2703. - PMC - PubMed
-
- Azoulay-Dupuis E, Moine P, Bédos J P, Rieux V, Vallée E. Amoxicillin dose-effect relationship with Streptococcus pneumoniae in a mouse pneumonia model and roles of in vitro penicillin susceptibilities, autolysis, and tolerance properties of the strains. Antimicrob Agents Chemother. 1996;40:941–946. - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
